(Q36621550)

15 August 2017

Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells (English)

1 reference

15 August 2017

9

G Vogelsang

1 reference

15 August 2017

E van der Wall

1

1 reference

15 August 2017

T Horn

2

1 reference

15 August 2017

E Bright

3

1 reference

15 August 2017

J L Passos-Coehlo

4

1 reference

15 August 2017

S Bond

5

1 reference

15 August 2017

B Clarke

6

1 reference

15 August 2017

V Altomonte

7

1 reference

15 August 2017

K McIntyre

8

1 reference

15 August 2017

S J Noga

10

1 reference

15 August 2017

J M Davis

11

1 reference

15 August 2017

J Thomassen

12

1 reference

15 August 2017

K V Ohly

13

1 reference

15 August 2017

S M Lee

14

1 reference

15 August 2017

J Fetting

15

1 reference

15 August 2017

D K Armstrong

16

1 reference

15 August 2017

N E Davidson

17

1 reference

15 August 2017

A D Hess

18

1 reference

15 August 2017

M J Kennedy

19

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

83

1 reference

15 August 2017

11

1 reference

15 August 2017

1405-1411

1 reference

Much ado about not...enough data: high-dose chemotherapy with autologous stem cell rescue for breast cancer

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363431

Developing and shedding inhibitions: how MHC class II molecules reach maturity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363431

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363431

Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363431

HLA-DR antigens on differentiating human mammary gland epithelium and breast tumours

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363431

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363431

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363431

The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363431

The skin biopsy in the diagnosis of acute graft-versus-host disease in man

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363431

Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363431

Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363431

Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363431

Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363431

Induction of graft-versus-host disease after autologous bone marrow transplantation.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363431

Reappraisal of histologic features of the acute cutaneous graft-versus-host reaction based on an allogeneic rodent model.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363431

Complexity of effector mechanisms in cyclosporine-induced syngeneic graft-versus-host disease

20 September 2018

1 reference

12 December 2020

High-dose chemotherapy in metastatic breast cancer

1 reference

12 December 2020

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

12 December 2020

Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets

1 reference

12 December 2020

Flow cytometric analysis of tumour infiltrating lymphocyte activation and tumour cell MHC Class I and II expression in breast cancer patients

1 reference

12 December 2020

Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy

1 reference

12 December 2020

Histologic comparison of autologous graft-vs-host reaction and cutaneous eruption of lymphocyte recovery

1 reference

12 December 2020

Cyclosporine-induced autologous graft versus host disease: assessment of cytolytic effector mechanisms and the V beta T-cell receptor repertoire

1 reference

12 December 2020

Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression

1 reference

12 December 2020

Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptide

1 reference

12 December 2020

Specificity of effector mechanisms in syngeneic graft-vs-host disease: recognition of the MHC class II invariant chain peptide (CLIP)

1 reference

12 December 2020

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

1 reference

12 December 2020

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.2000.1499

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

11076645

1 reference